The COVID-19 disease caused by the novel coronavirus (SARS-CoV-2) created a public health crisis that has strained communities and healthcare systems around the world. Although, evolving research enables physicians to treat the complications of COVID-19 disease more effectively in emergency departments and intensive care units (ICU) worldwide.
Atrial fibrillation (Afib) is a strong risk factor for life-threatening diseases but thankfully, early detection of Atrial Fibrillation can save lives. However, in some cases, the arrhythmia remains undiagnosed until the patient is admitted to the hospital to manage an acute event such as a stroke.
Atrial fibrillation (AFib) is an abnormal heart rhythm that can occur suddenly and without warning. Characterized by skipping heartbeats and a racing heart rate, AFib can occur in people with heart conditions – but it can also occur in those without any known heart problems.